Introduction Cardiovascular disease (CVD) is the leading cause of death in patients with
inflammatory polyarthritis (IP), especially in seropositive disease. In established rheumatoid …

Background Patients with rheumatoid arthritis (RA) are at increased risk of developing
cardiovascular disease (CVD). Our aim was to evaluate the impact of factors related to CVD …

Objective The 2013 American College of Cardiology/American Heart Association cholesterol
treatment guidelines recommend statins for patients with diabetes mellitus ages 40–75 …

Objective Systemic inflammation and insulin resistance (IR) are linked, yet the determinants
of IR and its impact on atherosclerosis in rheumatoid arthritis (RA) are incompletely …

Rheumatoid arthritis (RA) patients experience a markedly increased frequency of
cardiovascular disease. We evaluated cardiovascular risk profiles in 79 RA patients and in …

Objectives To describe the prevalence of insulin resistance (IR) in patients with established
rheumatoid arthritis (RA) and to analyse the contribution of cumulative inflammatory burden …

Over the past decade, a large number of investigations on cardiovascular disease (CVD) in
rheumatoid arthritis (RA) have been reported. This followed the earlier seminal observations …

Introduction Co-morbidity and mortality due to cardiovascular disease (CVD) are increased
in patients with rheumatoid arthritis (RA). Most published studies in this field are …

Background Rheumatoid arthritis (RA) is characterized by increased cardiovascular (CV)
mortality. CV events are particularly high in patients with RA-specific autoimmunity, including …

Introduction Patients with rheumatoid arthritis (RA) have increased risk of cardiovascular
(CV) events. We sought to test the hypothesis that due to increased inflammation, CV …